| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/06/2011 | CN102114076A Preparation method of cassia bark extract, cassia bark extract and composition and application thereof |
| 07/06/2011 | CN102114074A Traditional Chinese medicine for treating diabetic diarrhea |
| 07/06/2011 | CN102114062A Method for producing pine pollen nutrition powder for treating child sexual precocity |
| 07/06/2011 | CN102114032A Nutritional composition for improving immune function of poultry |
| 07/06/2011 | CN102114029A Water-soluble vitamin powder injection without preservative and preparation method thereof |
| 07/06/2011 | CN102114018A Compound controlled-release tablet with effect of regulating blood lipid and preparation method thereof |
| 07/06/2011 | CN102114017A Medicinal composition containing amlodipine and perindopril and application thereof |
| 07/06/2011 | CN102114002A Enhanced immediate release formulations of topiramate |
| 07/06/2011 | CN102114001A Orally administered solid preparation containing tolvaptan |
| 07/06/2011 | CN102113996A Oral formulations containing protein or peptide, and preparation method and application thereof |
| 07/06/2011 | CN102113984A Composite with function of reducing weight of abdomen |
| 07/06/2011 | CN102113534A Moon cake with function of treating diabetes and preparation method thereof |
| 07/06/2011 | CN101810620B Methionine-vitamin B1 composite injection and preparation method thereof |
| 07/06/2011 | CN101549008B Application of high-pressure continous extracted cassia seed extract in preparing hypolipemic medicine |
| 07/06/2011 | CN101538569B RNA and recombinant for inhibiting human DMT1 protein and application thereof |
| 07/06/2011 | CN101524488B Preparation method of compound bamboo leave flavone dripping pill |
| 07/06/2011 | CN101461782B Sub-microemulsion preparation for levocarnitine injection and preparation method thereof |
| 07/06/2011 | CN101198614B Thienopyrimidine derivative |
| 07/06/2011 | CN101133026B 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 07/06/2011 | CN101099752B Method for extracting pollen essential from Chinese pine pollen |
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973159 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 07/05/2011 | US7973052 Compounds for the treatment of metabolic disorders |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973030 Benzothiazepine and benzothiepine compounds |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | CA2627038C Beverage |
| 07/05/2011 | CA2564563C Indolyl derivatives as liver-x-receptor modulators |
| 07/05/2011 | CA2555064C A pharmaceutical composition |
| 07/05/2011 | CA2517571C Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 07/05/2011 | CA2489456C Gangliosides with a modified acyl function |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2473663C Ubiquinone-enriched foods |
| 07/05/2011 | CA2451866C Nutritional composition preventing bacterial overgrowth |
| 07/05/2011 | CA2345027C Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| 06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
| 06/30/2011 | WO2011078785A1 Diacylglycerol based alpha-lipoic acid derivatives as antioxidants and agents for blocking food intake |
| 06/30/2011 | WO2011078426A1 Peptide for suppressing and treating obesity |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078371A1 Novel 3-hydroxy-5-arylisothiazole derivative |
| 06/30/2011 | WO2011078370A1 Novel parabanic acid derivative and drug having the same as active ingredient |
| 06/30/2011 | WO2011078367A1 Emulsion composition |
| 06/30/2011 | WO2011078306A1 Gpr119 agonist |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078213A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
| 06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
| 06/30/2011 | WO2011078102A1 Novel phenoxypyrimidine derivative |
| 06/30/2011 | WO2011077843A1 Atrovastatin-containing coated preparation |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011076721A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| 06/30/2011 | WO2011075935A1 Diphenylethene derivatives and uses thereof |
| 06/30/2011 | WO2011075784A1 Compounds, preparations and uses thereof |
| 06/30/2011 | WO2011055289A3 Carboxy oxazole or thiazole compounds as dgat - 1 inhibitors useful for the treatment of obesity |
| 06/30/2011 | WO2011048148A3 Glycoside derivative and uses thereof |
| 06/30/2011 | WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 06/30/2011 | WO2010092123A8 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia |
| 06/30/2011 | WO2007113540A8 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110160845 Drug delivery system and method of manufacturing thereof |
| 06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 06/30/2011 | US20110160305 Oral Delivery of Therapeutic Doses of Glutathione |
| 06/30/2011 | US20110160296 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
| 06/30/2011 | US20110160274 Fenofibrate formulation with enhanced oral bioavailability |
| 06/30/2011 | US20110160267 Method of treating diabetic retinopathy |
| 06/30/2011 | US20110160257 Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 06/30/2011 | US20110160253 Deuterated tizanidine |
| 06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 06/30/2011 | US20110160241 New peptidomimetic compounds |
| 06/30/2011 | US20110160238 Octahydroquinolizines for antidiabetic treatment |
| 06/30/2011 | US20110160236 Treating Vascular Events with Statins by Inhibiting PAR-1 and PAR-4 |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
| 06/30/2011 | US20110160225 Compositions and methods of use for treating or preventing lipid related disorders |
| 06/30/2011 | US20110160222 Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders |
| 06/30/2011 | US20110160220 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 06/30/2011 | US20110160217 Deuterium enriched analogues of tadalafil as pde5 inhibitors |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160212 Certain dipeptidyl peptidase inhibitors |
| 06/30/2011 | US20110160211 Cyclopentylacrylamide derivative |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160202 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 06/30/2011 | US20110160198 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 06/30/2011 | US20110160191 New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 06/30/2011 | US20110160186 Methods of Treating CYP2D6 Alternative Metabolizers |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160179 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 06/30/2011 | US20110160174 Method Of Treating Disorder Related To High Cholesterol Concentration |
| 06/30/2011 | US20110160165 7-Pyrazolyl Tetracycline Compounds and Methods of Use Thereof |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160149 Pharmaceutical Composition for a Hepatitis C Viral Protease Inhibitor |
| 06/30/2011 | US20110160136 Polyphenols for the treatment of cartilage disorders |